APA Schizophrenia

Thoughts about the current state of psychiatry by Psychiatric Times' Editor in Chief.

The personalized medicine approach is predicated upon a greater understanding of the biology of illness and how it plays out-uniquely and specifically-for each individual patient.

When treating psychosis, dementia, addiction, and other psychiatric illnesses in older patients, clinicians must be prepared for a multitude of scenarios.

Here’s an overview on the latest from the Chair of the Scientific Program Committee of APA 2016.

What are the pros and cons of marijuana use? Dr Andrew Saxon gives his viewpoint on why he is against medical marijuana but in favor of legalization of recreational use of marijuana.

Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations-usually in under 2 minutes.

An analysis of symptom severity across domains may enable us to reevaluate how we categorize symptoms within the spectrum of psychotic illness.

Physicians recognize many features of schizophrenia, but one neglected area is the common symptom of a poor self-other boundary-in fact, this has also been neglected as a criterion for the DSM.

Multiple perspectives are required to fully understand a concept. This seems to be the growing consensus with the schizophrenia spectrum disorders.

If the models in this discussion are disseminated and used, costs will drop and patients will enjoy an improved quality of life.

“Those who fail to learn from the mistakes of their predecessors are destined to repeat them.” This may be the take-home point of the APA 2015 meeting regarding schizophrenia.

Here is just a sample of the many great presentations on schizophrenia at this year’s meeting.